BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is being made by the Company to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
Shares of common stock are being offered through an underwritten public offering.
Use of Proceeds
Proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms.
- The Company's intention to use the net proceeds from the offering for specific purposes signals strategic financial decisions.
- The offering is made pursuant to a shelf registration statement declared effective by the SEC on December 17, 2024.
BioSig Technologies Inc.'s proposed public offering reflects strategic decisions to fund operations and investments in gold bullion.